ISSN: 2155-9570
Jerry Katzman
Emeritus New York Medical, USA
Keynote: J Clin Exp Ophthalmol
1. Retinal Genix system: A 200 degree FOV ophthalmic imaging camera screening device. The device would be affordable and easy to use by not only by Ophthalmologists, Optometrists, Opticians, and eye care professionals but by other medical specialties as well to prevent blindness. General practitioners, pediatricians and hospitals are screening sites. The imaging system would allow for retinal imaging fast, efficient, easy to operate and through an undilated pupil for mass screening. As the earliest signs of diabetes is detected by vascular changes in the peripheral retina and diabetes is the most common cause of blindness, early detection would reduce the dire onset of diabetic retinopathy DR, diabetic macula edema DME
2. Retinalcam: A patient home undilated monitoring imaging system with physician alert for the monitoring by patients themselves. These patients are considered high risk for loss of sight and eventual blindness. Immediate intervention is needed in patients with diabetic retinopathy, AMD (wet and dry), optic neuritis, hemorrhage, stroke, vasculitis, optic neuritis and other pathologies. Once identified by their physician, continuous home monitoring becomes not only possible but sight saving.
Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology. Katzman graduated from Boston University with a B.S. in Biomedical Engineering in 1974 and thereafter earned his M.D. from the Universidad de Guadalajara in Jalisco, Mexico. He has several articles and abstracts publications.